Related references
Note: Only part of the references are listed.Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
Carlo Cervellati et al.
MINERVA MEDICA (2019)
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
Carlo Cervellati et al.
ATHEROSCLEROSIS (2019)
Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
Debora Levy et al.
ANTIOXIDANTS (2019)
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women
Carlo Cervellati et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2018)
OxInflammation: From Subclinical Condition to Pathological Biomarker
Giuseppe Valacchi et al.
FRONTIERS IN PHYSIOLOGY (2018)
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
Angelina Passaro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Lactonase Activity and Lipoprotein-Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study
Joussef Hayek et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia
Malgorzata Bednarska-Makaruk et al.
BIOGERONTOLOGY (2017)
Transcriptional regulation of human Paraoxonase 1 by nuclear receptors
N. Ponce-Ruiz et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis
Peter Fulop et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Paraoxonases-1,-2 and-3: What are their functions?
Clement E. Furlong et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
OxInflammation in Rett syndrome
Alessandra Pecorelli et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
Massimiliano Castellazzi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Nicholas J. Woudberg et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Association between circulatory levels of adipokines and bone mineral density in postmenopausal women
Carlo Cervellati et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2016)
Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192
Geetika Aggarwal et al.
PLOS ONE (2016)
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
Mike Mackness et al.
GENE (2015)
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study
Carlo Cervellati et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Inverse Correlation Between Circulating Levels of TNF-Related Apoptosis-Inducing Ligand and 17β-Estradiol
Giorgio Zauli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Modulation of Circulating Cytokine-Chemokine Profile in Patients Affected by Chronic Venous Insufficiency Undergoing Surgical Hemodynamic Correction
Veronica Tisato et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
Saar Aharoni et al.
ATHEROSCLEROSIS (2013)
Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway
Chi-Chih Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Associations of PON1 and Genetic Ancestry with Obesity in Early Childhood
Karen Huen et al.
PLOS ONE (2013)
Adipokines Mediate Inflammation and Insulin Resistance
Hyokjoon Kwon et al.
Frontiers in Endocrinology (2013)
Paraoxonase 1: A better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus
Surajeet Kumar Patra et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2013)
17β-estradiol levels and oxidative balance in a population of pre-, peri-, and post-menopausal women
Carlo Cervellati et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
Inflammation, Oxidative Stress, and Obesity
Alba Fernandez-Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
PON-dering differences in HDL function in coronary artery disease
Chieko Mineo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Adipokines in inflammation and metabolic disease
Noriyuki Ouchi et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Human Paraoxonase-1 Activity in Childhood Obesity and Its Relation to Leptin and Adiponectin Levels
Peter Koncsos et al.
PEDIATRIC RESEARCH (2010)
Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1)
Su Duy Nguyen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
Judit Marsillach et al.
BMC GASTROENTEROLOGY (2009)
Validation of PON1 enzyme activity assays for longitudinal studies
Karen Huen et al.
CLINICA CHIMICA ACTA (2009)
The paraoxonases: role in human diseases and methodological difficulties in measurement
Jordi Camps et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Body mass index is a major determinant of abdominal fat accumulation in pre-, peri- and post-menopausal women
Carlo Cervellati et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
Relationship of adiponectin to serum paraoxonase 1
Laszlo Bajnok et al.
ATHEROSCLEROSIS (2008)
Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women
Thomas M. van Himbergen et al.
ATHEROSCLEROSIS (2008)
Relationship of Serum Resistin Level to Traits of Metabolic Syndrome and Serum Paraoxonase 1 Activity in a Population with a Broad Range of Body Mass Index
L. Bajnok et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress
Elena Thomas-Moya et al.
OBESITY (2008)
Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals
Laszlo Bajnok et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
The link between abdominal obesity, metabolic syndrome and cardiovascular disease
S. A. Ritchie et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients
Zsuzsa Varga et al.
NEPHRON CLINICAL PRACTICE (2006)
The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men
KW Oh et al.
CLINICAL ENDOCRINOLOGY (2005)
Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats
J Beltowski et al.
PHARMACOLOGICAL RESEARCH (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans
JN Fain et al.
ENDOCRINOLOGY (2004)
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells
B Mackness et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-10 and tumor necrosis factor-α, but is upregulated by interleukin-6
Y Kumon et al.
LIFE SCIENCES (2003)
Obesity and systemic oxidative stress - Clinical correlates of oxidative stress in the Framingham Study
JF Keaney et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Share Paper
